experienced lower mortality rates and better recovery times compared to those not getting the treatment.
The researchers compared 312 people hospitalized for COVID-19 and who received remdesivir to 818 people with similarly severe cases who were treated with standard of care, but did not need mechanical ventilation to breathe. Compared to the people in the latter group, those getting remdesivir showed a 62% lower risk of mortality during the study period. Furthermore, about 75% of patients receiving remdesivir recovered by day 14 after hospitalization, compared to 59% of those not getting the drug.
The analysis did not follow the rigorous gold standard of comparing an experimental treatment group to a control group within the same study, a method that ensures the two groups are similar as possible and better accounts for potentially confounding factors. A previous remdesivir study that met such criteria, conducted by the National institute of Allergy and Infectious Diseases and reported in late April,that people taking remdesivir had a shorter recovery time.
Gilead’s analysis is the next-best thing to a randomized placebo-controlled trial, and the company’s scientists acknowledge that more studies are needed to confirm the reduction in mortality. “To address the urgency of the continuing pandemic, we are sharing data with the research community as quickly as possible with the goal of providing transparent and timely updates on new developments with remdesivir,” Gilead Sciences Chief Medical Officer Merdad Parsey said in a statement.
Gilead also reported additional data showing that remdesivir provided similar benefit to people of racial and ethnic groups that seem to be
Kkkkkkk e vai falar o que ? Que é uma porcaria caríssima?
Remdisivir will be the heavenly drug for dear American citizens and will get them health to full life saving conditions...
It's an old news, 3 months ago, The Lancet stated the treatment with Remdesivir was not associated with statistically significant clinical benefits in adults with severe COVID-19, patients receiving Remdesivir showed a faster time to clinical improvement compared to placebo.
The fuck is this? I never followed this account